4 Experimental Ebola Therapies Approved for Use in Congo

Share this content:
4 Experimental Ebola Therapies Approved for Use in Congo
4 Experimental Ebola Therapies Approved for Use in Congo

WEDNESDAY, Aug. 22, 2018 (HealthDay News) -- Four more experimental treatments for Ebola virus have been approved by the Congo health ministry for use in an outbreak of the deadly infectious disease in the country's northeast.

The treatments are ZMapp, Remdesivir, Favipiravir, and Regn3450 - 3471 - 3479. On Aug. 11, health officials began using the experimental treatment mAb114 on 10 patients, and the ministry says they are doing well, the Associated Press reported.

The most recent Ebola outbreak in Congo was declared in Mangina in North Kivu province on Aug. 1. There have been 75 confirmed Ebola cases and 27 probable ones. Of 59 reported deaths, 32 have been confirmed as Ebola, according to the health ministry.

The ministry said that since Aug. 8, more than 1,600 people have been vaccinated in Mabalako and Beni in North Kivu province and in Mandima in Ituri province, the AP reported.

AP News Article
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Warns About 'Miracle' Young Blood Infusion Treatments

FDA Warns About 'Miracle' Young Blood Infusion Treatments

Expensive 'fountain of youth' therapies are unproven, potentially harmful

CDC: Salmonella Cases Tied to Raw Turkey Products Now at 279

CDC: <i>Salmonella</i> Cases Tied to Raw Turkey Products ...

Cases reported in 41 states and the District of Columbia; 107 people have been hospitalized

Chronic Wasting Disease Found in Deer in 24 States

Chronic Wasting Disease Found in Deer in 24 ...

No evidence disease can spread to humans, but hunters should be careful around potentially infected animals

is free, fast, and customized just for you!




Already a member?

Sign In Now »